ALKINDI SPRINKLE

临床试验

计划入组 36 人 · 首次发布于 2008 年 4 月 1 日

已完成

NCT00649740

Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

计划入组 36 人 · 首次发布于 2008 年 4 月 1 日

已完成

NCT00649467

Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

计划入组 35 人 · 首次发布于 2008 年 4 月 1 日

药物

查看全部 11 →

Small Molecule

Approved

Valbenazine(Ingrezza)

相关疾病：Chorea, Tardive Dyskinesia (TD)

C₂₄H₃₈N₂O₄ · Rx

Small Molecule

Approved

Topiramate(Eprontia, Qsymia, Qudexy, Topamax, Trokendi)

生产企业：Ortho mcneil janssen pharmaceuticals inc, Barr laboratories inc，另有 18 家

相关疾病：Alcohol Dependency, Epilepsy, Primary Generalized Tonic-Clonic Seizures，另有 7 项

C₁₂H₂₁NO₈S · Rx

Small Molecule

Approved

Fesoterodine(Toviaz)

相关疾病：Neurogenic Detrusor Overactivity, Overactive Bladder Syndrome (OABS)

C₂₆H₃₇NO₃ · Rx

机构

ALLKINDS PTY LTD

Australia

资讯

查看全部 21 →

2年前

Eton Pharmaceuticals Submits NDA to FDA for ET-400 (Hydrocortisone Oral Solution)

2年前

Eton Pharmaceuticals' ET-400 (Hydrocortisone Oral Solution) Receives FDA Acceptance

去年

临床试验

Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

药物

Valbenazine(Ingrezza)

Topiramate(Eprontia, Qsymia, Qudexy, Topamax, Trokendi)

Fesoterodine(Toviaz)

机构

ALLKINDS PTY LTD

资讯

Eton Pharmaceuticals Submits NDA to FDA for ET-400 (Hydrocortisone Oral Solution)

Eton Pharmaceuticals' ET-400 (Hydrocortisone Oral Solution) Receives FDA Acceptance

Eton Pharmaceuticals Receives FDA Approval for KHINDIVI, First Hydrocortisone Oral Solution for Pediatric Adrenal Insufficiency